Insulet Corp Files 8-K on Operations and Financials

Ticker: PODD · Form: 8-K · Filed: 2024-07-26T00:00:00.000Z

Sentiment: neutral

Topics: 8-K, financial-reporting, operations

TL;DR

Insulet filed an 8-K on July 26, 2024, updating on financials and operations.

AI Summary

On July 26, 2024, Insulet Corporation filed an 8-K report to disclose information regarding its results of operations and financial condition, as well as financial statements and exhibits. The filing does not contain specific financial figures or operational details beyond the reporting of these categories.

Why It Matters

This filing indicates Insulet Corporation is providing updates on its financial performance and operational status, which is crucial for investors to assess the company's health.

Risk Assessment

Risk Level: low — The filing is a standard disclosure of operational and financial information without any immediate negative or positive catalysts mentioned.

Key Players & Entities

FAQ

What specific items are being reported under 'Results of Operations and Financial Condition'?

The filing does not specify the exact details of the results of operations and financial condition, only that this category is being reported.

What is the purpose of filing 'Financial Statements and Exhibits'?

The purpose is to provide the necessary financial statements and supporting exhibits as required by the SEC for this report.

When was the earliest event reported in this 8-K?

The earliest event reported is July 26, 2024, which is also the date of the report.

What is Insulet Corporation's state of incorporation?

Insulet Corporation is incorporated in Delaware.

What is the IRS Employer Identification Number for Insulet Corporation?

The IRS Employer Identification Number for Insulet Corporation is 04-3523891.

From the Filing

0001145197-24-000031.txt : 20240726 0001145197-24-000031.hdr.sgml : 20240726 20240726062909 ACCESSION NUMBER: 0001145197-24-000031 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240726 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240726 DATE AS OF CHANGE: 20240726 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INSULET CORP CENTRAL INDEX KEY: 0001145197 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 043523891 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-33462 FILM NUMBER: 241143510 BUSINESS ADDRESS: STREET 1: 100 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 BUSINESS PHONE: 978-600-7000 MAIL ADDRESS: STREET 1: 100 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 8-K 1 podd-20240726.htm 8-K podd-20240726 0001145197 FALSE 0001145197 2024-07-26 2024-07-26 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 8-K   CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported):  July 26, 2024   INSULET CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-33462 04-3523891 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 100 Nagog Park Acton Massachusetts 01720 (Address of Principal Executive Offices, including Zip Code) Registrant’s telephone number, including area code: (978) 600-7000 Not Applicable (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter) Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐ Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.001 Par Value Per Share PODD The NASDAQ Stock Market, LLC Item 2.02 Results of Operations and Financial Condition. On July 26, 2024, Insulet Corporation issued a press release announcing preliminary revenue results for the second quarter ended June 30, 2024 as well as expected total Omnipod guidance for 2024. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein in its entirety by reference. Limitation on Incorporation by Reference. The information furnished in this Item 2.02, including the press release attached hereto as Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities

View on Read The Filing